Technology

Pipeline

High-specificity cancer targeting

Using its proprietary platform technology, EM Imaging is developingĀ a pipeline of highly novel in vivo c-Met targeting theragnostic and optical imaging agents that will alter the landscape of precision medicine.

Find out about our Technology

Pipeline

Edinburgh Molecular Imaging as a portfolio of agents addressing a number of unmet medical needs.

Find out about Pipeline

Ongoing Clinical Studies

adminHome